// App-Quantinova.ai

: Longitudinal Changes of Impairments in Health-Related Quality of Life in Lower-Risk MDS Patients: A European Leukemianet Study

Researchers

Presenter

  • Reinhard Stauder

Principal Investigators

  • Karin A Koinig

  • Dominic Culligan

  • Pierre Fenaux

  • Jaroslav Cermak

  • Argiris Symeonidis

  • Teresa Bernal

  • Eva Hellstrm-Lindberg

  • Moshe Mittelman

  • Saskia Langemeijer

  • Mette Skov Holm

  • Juliet Mills

  • Agns Guerci-Bresler

  • Corine van Marrewijk

  • Hege Garelius

  • Fabio Efficace

  • Alexandra Smith

  • David Bowen

  • Theo M de Witte

Medical Centers

  • Department of Internal Medicine V (Hematology and Oncology), Innsbruck Medical University (IMU), Innsbruck, Innsbruck, Austria

  • Epidemiology&Genetics Unit, Department of Health Sciences, University of York, York, United Kingdom

  • Department of Internal Medicine V (Hematology and Oncology), Innsbruck Medical University (IMU), Innsbruck, Innsbruck, Austria

  • Dept of Microbiology, Aberdeen Royal Infirmary, Aberdeen, United Kingdom

  • Service d'Hématologie Séniors, Hôpital Saint-Louis, Assistance Publique-Hôpitaux de Paris and Université Paris 7,Paris,France

  • Institute of Hematology and Blood Transfusion, Prague, Czech Republic

  • Department of Internal Medicine, Division of Hematology, University of Patras Medical School, Patras, Greece

  • Dep of Hematology and Hemotherapy, University Hospital Central de Asturias, Oviedo, Spain

  • Center for Hematology and Regenerative Medicine (HERM), Department of Medicine, Karolinska Institutet, Stockholm, Sweden

  • Internal diseases, Tel Aviv Sourasky Medical Center, Tel Aviv, Israel

  • Department of Urology, Radboud University Medical Center, Nijmegen, Netherlands

  • Department of Hematology, Aarhus University Hospital, Aarhus, Denmark

  • Hematology,Acute Hospitals NHS Trust and University of Birmingham,Birmingham,United Kingdom

  • Service d'Hématologie, Centre Hospitalier Universtaire Brabois, Vandoeuvre-lès-Nancy, France

  • Dep. of Medicine, Sect. of Hematology and Coagulation, Sahlgrenska University Hospital, Göteborg, Sweden

  • Gruppo Italiano Malattie Ematologiche dellAdulto (GIMEMA), Rome, Italy

  • Epidemiology and Cancer Statistics Group, Department of Health Sciences,University of York,York,United Kingdom

  • Department of Histopathology, Leeds Teaching Hospitals NHS Foundation Trust, Leeds, United Kingdom

  • Dep. of Tumor Immunology - Nijmegen Center for Molecular Life Sciences, Radboud University Medical Centre, Nijmegen, Netherlands

Locations

  • Austria

  • United Kingdom

  • France

  • Czech Republic

  • Greece

  • Spain

  • Sweden

  • Israel

  • Netherlands

  • Italy

Companies

  • N/A

Study Components

Therapeutic Area

  • N/A

Disease

  • N/A

Biomarkers

  • Tyrosine 3-Monooxygenase/Tryptophan 5-Monooxygenase Activation Protein Epsilon

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • Non Interventional

  • Prospective

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved